All In Biotech

Investigational drug · Phase 2

DISC-0974

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia.

Phase 2

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

4

Any phase or sponsor naming "DISC-0974"

First trial start

2022

Jun 6, 2022

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "DISC-0974", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Anemia
  • Inflammatory Bowel Disease (IBD)
  • Inflammatory Bowel Disease (IBD); Anemia
  • Myelofibrosis; Anemia
  • Myelofibrosis
  • Myelofibrosis Due to and Following Polycythemia Vera
  • Primary Myelofibrosis
  • Post-essential Thrombocythemia Myelofibrosis
  • Myelodysplastic Syndromes

Approved drugs for the same conditions: Myelodysplastic syndromes · Myelofibrosis · Anemia · Hematology and blood cancers · Cardiovascular and metabolic · Immunology and inflammation · Rare and genetic disease · Gastroenterology and liver

Largest trials

Live from ClinicalTrials.gov: studies naming "DISC-0974" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 4 on PubMed

Also in development for Anemia

  • ElriterceptTAK-226, KER-050Phase 36 trials

    Takeda · Myelodysplastic Syndromes, Myelofibrosis, Anemia

  • BCD-131pegdarbepoetin betaPhase 31 trial

    Biocad · Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis

  • OfirnoflastHT-6184Phase 22 trials

    Halia Therapeutics, Inc. · Myelodysplastic Syndromes, Anemia, Myelodysplastic Syndrome

  • SAL-0951SAL-0951 groupPhase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Anemia

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.